Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.verified

ARQT

Price:

$31.16

Market Cap:

$3.82B

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known...[Read more]

Industry

Biotechnology

IPO Date

2020-01-31

Stock Exchange

NASDAQ

Ticker

ARQT

The ROE as of December 2025 (TTM) for Arcutis Biotherapeutics, Inc. (ARQT) is -29.69%

According to Arcutis Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -29.69%. This represents a change of 281.10% compared to the average of -7.79% of the last 4 quarters.

Arcutis Biotherapeutics, Inc. (ARQT) Historical ROE (quarterly & annually)

How has ARQT ROE performed in the past?

The mean historical ROE of Arcutis Biotherapeutics, Inc. over the last ten years is -51.01%. The current -29.69% ROE has changed -41.80% with respect to the historical average. Over the past ten years (40 quarters), ARQT's ROE was at its highest in in the September 2019 quarter at 27.35%. The ROE was at its lowest in in the March 2018 quarter at -138.32%.

Quarterly (TTM)
Annual

Average

-51.01%

Median

-59.73%

Minimum

-295.65%

Maximum

99.70%

Arcutis Biotherapeutics, Inc. (ARQT) ROE by Quarter and Year

Discovering the peaks and valleys of Arcutis Biotherapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 114.38%

Maximum Annual ROE = 99.70%

Minimum Annual Increase = -177.63%

Minimum Annual ROE = -295.65%

Quarterly (TTM)
Annual
YearROEChange
2024-88.89%-69.93%
2023-295.65%98.94%
2022-148.61%114.38%
2021-69.32%38.27%
2020-50.14%-177.63%
201964.58%-19.55%
201880.27%-19.49%

Arcutis Biotherapeutics, Inc. (ARQT) Average ROE

How has ARQT ROE performed in the past?

The current ROE of Arcutis Biotherapeutics, Inc. (ARQT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-177.72%

5-year avg

-130.52%

10-year avg

-51.01%

Arcutis Biotherapeutics, Inc. (ARQT) ROE vs. Peers

How is ARQT’s ROE compared to its peers?

Arcutis Biotherapeutics, Inc.’s ROE is greater than Tarsus Pharmaceuticals, Inc. (-26.29%), less than Amicus Therapeutics, Inc. (9.67%), greater than Travere Therapeutics, Inc. (-178.68%), greater than Zai Lab Limited (-27.32%), greater than Legend Biotech Corporation (-30.95%), greater than Disc Medicine, Inc. (-31.61%), greater than CG Oncology, Inc. Common stock (-15.40%), greater than Centessa Pharmaceuticals plc (-56.47%), greater than Xenon Pharmaceuticals Inc. (-38.50%), greater than Celcuity Inc. (-179.00%),

Build a custom stock screener for Arcutis Biotherapeutics, Inc. (ARQT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcutis Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcutis Biotherapeutics, Inc. (ARQT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcutis Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Arcutis Biotherapeutics, Inc.'s ROE?

How is the ROE calculated for Arcutis Biotherapeutics, Inc. (ARQT)?

What is the highest ROE for Arcutis Biotherapeutics, Inc. (ARQT)?

What is the 3-year average ROE for Arcutis Biotherapeutics, Inc. (ARQT)?

What is the 5-year average ROE for Arcutis Biotherapeutics, Inc. (ARQT)?

How does the current ROE for Arcutis Biotherapeutics, Inc. (ARQT) compare to its historical average?